BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22251240)

  • 1. Ciprofloxacin hydrochloride-loaded glyceryl monostearate nanoparticle: factorial design of Lutrol F68 and Phospholipon 90G.
    Shah M; Agrawal Y
    J Microencapsul; 2012; 29(4):331-43. PubMed ID: 22251240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
    Vivek K; Reddy H; Murthy RS
    AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation of acyclovir-loaded solid lipid nanoparticles: design, optimization, and
    El-Gizawy SA; El-Maghraby GM; Hedaya AA
    Pharm Dev Technol; 2019 Dec; 24(10):1287-1298. PubMed ID: 31507232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery.
    Rawat MK; Jain A; Mishra A; Muthu MS; Singh S
    Ther Deliv; 2010 Jul; 1(1):63-73. PubMed ID: 22816120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.
    Thirupathi G; Swetha E; Narendar D
    Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design.
    Hao J; Fang X; Zhou Y; Wang J; Guo F; Li F; Peng X
    Int J Nanomedicine; 2011; 6():683-92. PubMed ID: 21556343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery.
    Jain D; Banerjee R
    J Biomed Mater Res B Appl Biomater; 2008 Jul; 86(1):105-12. PubMed ID: 18098198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on paclitaxel-loaded glyceryl monostearate nanoparticles.
    Shenoy VS; Rajyaguru TH; Gude RP; Murthy RS
    J Microencapsul; 2009 Sep; 26(6):471-8. PubMed ID: 19169921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of solid lipid nanoparticles from W/O/W emulsions: preliminary studies on insulin encapsulation.
    Gallarate M; Trotta M; Battaglia L; Chirio D
    J Microencapsul; 2009 Aug; 26(5):394-402. PubMed ID: 18785076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Development of Sertraline Loaded Solid Lipid Nanoparticle (SLN) by Emulsification-Ultrasonication Method and Pharmacokinetic Study in Sprague-Dawley Rats.
    Rahman MA; Harwansh RK; Iqbal Z
    Pharm Nanotechnol; 2019; 7(2):162-176. PubMed ID: 30919786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid Lipid Nanoparticles of Dronedarone Hydrochloride for Oral Delivery: Optimization, In Vivo Pharmacokinetics and Uptake Studies.
    Gambhire VM; Gambhire MS; Ranpise NS
    Pharm Nanotechnol; 2019; 7(5):375-388. PubMed ID: 31376827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Solid Lipid Nanocarrier of Glibenclamide: A Factorial Design Approach with Response Surface Methodology.
    Pandey S; Patel P; Gupta A
    Curr Pharm Des; 2018; 24(16):1811-1820. PubMed ID: 29788881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of solid lipid nanoparticles containing peptide.
    Hu FQ; Hong Y; Yuan H
    Int J Pharm; 2004 Apr; 273(1-2):29-35. PubMed ID: 15010127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release.
    Luan J; Zhang D; Hao L; Li C; Qi L; Guo H; Liu X; Zhang Q
    Drug Deliv; 2013 Nov; 20(8):324-30. PubMed ID: 24032657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.
    Peng LH; Wei W; Shan YH; Chong YS; Yu L; Gao JQ
    Drug Dev Ind Pharm; 2017 Jan; 43(1):55-66. PubMed ID: 27498809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through topical delivery.
    Chen X; Peng LH; Shan YH; Li N; Wei W; Yu L; Li QM; Liang WQ; Gao JQ
    Int J Pharm; 2013 Apr; 447(1-2):171-81. PubMed ID: 23500766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization.
    Varia JK; Dodiya SS; Sawant KK
    Curr Drug Deliv; 2008 Jan; 5(1):64-9. PubMed ID: 18220553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly[LA-(Glc-Leu)] copolymer as a carrier for ocular delivery of ciprofloxacin: formulation, characterization and in vivo biocompatibility study.
    Pagar KP; Vavia PR
    Ther Deliv; 2013 May; 4(5):553-65. PubMed ID: 23647274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.